WallStSmart
KOD

Kodiak Sciences Inc

NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY

$108.25
-1.00% today

Updated 2026-11-12

Market cap
$6.87B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.19
Dividend yield
—
52W range
$18 – $112
Volume
2.1M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
4.0
Quality
C
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
-7.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →259 stocks currently score above 75

Price targets

Analyst target
$121.67
+12.40%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -7.30 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-46.59M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-333.82M$-260.49M$-176.21M$-229.97M$-65.64M
EPS————$-4.19
Free cash flow$-253.82M$-195.61M$-117.72M$-136.51M$-46.59M
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
KOD$6.87B254.33.05.04.0—Avoid
LLY$1.26T749.310.05.06.0—Strong Buy
JNJ$657.68B544.78.53.75.5—Buy
ABBV$521.11B776.79.04.05.0-85.21%Strong Buy
MRK$368.89B443.36.52.05.0-72.89%Hold
UNH$365.29B626.76.04.75.5-20.81%Buy

Smart narrative

Kodiak Sciences Inc trades at $108.25. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -7.30, it sits in the distress.

Frequently asked questions

What is Kodiak Sciences Inc's stock price?

Kodiak Sciences Inc (KOD) trades at $108.25.

Is Kodiak Sciences Inc overvalued?

Kodiak Sciences Inc carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Kodiak Sciences Inc (KOD)?

The 12-month analyst consensus target is $121.67, about 12.4% above the current $108.25. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Kodiak Sciences Inc's Altman Z-Score is -7.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-205.76%
Beta1.98
50D MA$72.36
200D MA$44.66
Shares out0.06B
Float0.04B
Short ratio—
Avg volume2.1M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—